Thursday, April 28, 2016

BRIEF-Celgene says 2020 Revlimid forecast is conservative: conf call

April 28 (Reuters) - Celgene Execs Say Otezla Continues To

Grow At Similar Rate After Novartis' Cosentyx Launch - Conf Call

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)